Biodistribution and toxicity evaluation of sesbania mosaic virus nanoparticles in mice

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Archives of Virology

• Publication date

  2016-07-09

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s00705-016-2958-9PMID 27395369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles

  2016cited by this paper
• The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft‐Matter Nanorods

  2015cited by this paper
• Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects

  2015cited by this paper
• Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.

  2014cited by this paper
• Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?

  2014cited by this paper
• Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.

  2014cited by this paper
• The splenocyte proliferative response and cytokine secretion in mice after 28-day oral administration of silver nanocolloid.

  2014cited by this paper
• Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells

  2014cited by this paper
• Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

  2013cited by this paper
• Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine

  2013cited by this paper
• Development of viral nanoparticles for efficient intracellular delivery.

  2012cited by this paper
• Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations

  2012cited by this paper
• Toxicology of nanoparticles.

  2012cited by this paper
• Optical nano-constructs composed of genome-depleted brome mosaic virus doped with a near infrared chromophore for potential biomedical applications.

  2011cited by this paper
• Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations

  2011cited by this paper
• Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration.

  2011cited by this paper
• Applications of viral nanoparticles in medicine.

  2011cited by this paper
• In vivo biodistribution of nanoparticles.

  2011cited by this paper
• Structure and assembly of Sesbania mosaic virus

  2010cited by this paper
• Potato virus X as a novel platform for potential biomedical applications.

  2010cited by this paper
• Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo

  2009cited by this paper
• Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague-Dawley rats.

  2008cited by this paper
• Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo

  2007cited by this paper
• Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver

  2007cited by this paper
• Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

  2007influential reference
• Striking out at disseminated metastases: the systemic delivery of oncolytic viruses.

  2006cited by this paper
• Viral nanoparticles as tools for intravital vascular imaging

  2006influential reference
• Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation.

  2006cited by this paper
• Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging.

  2006cited by this paper
• Systemic trafficking of plant virus nanoparticles in mice via the oral route.

  2005cited by this paper
• Paramagnetic viral nanoparticles as potential high‐relaxivity magnetic resonance contrast agents

  2005cited by this paper
• The role of arginine-rich motif and beta-annulus in the assembly and stability of Sesbania mosaic virus capsids.

  2005cited by this paper
• An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold.

  2005cited by this paper
• Immunological factors that affect the in vivo fate of T7 phage in the mouse.

  2004cited by this paper
• Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

  2004cited by this paper
• Scavenger receptors in innate immunity.

  2002cited by this paper
• A molecular switch in the capsid protein controls the particle polymorphism in an icosahedral virus.

  2002cited by this paper
• Complete nucleotide sequence of Sesbania mosaic virus: a new virus species of the genus Sobemovirus

  2001cited by this paper
• Structure of sesbania mosaic virus at 3 A resolution.

  1997cited by this paper
• Structure of Sesbania mosaic virus at 3 A resolution.

  1995cited by this paper
• Use of Direct Antigen Coating and Protein A Coating ELISA Procedures for Detection of Three Peanut Viruses.

  1987cited by this paper
• Clinical Guide to Laboratory Tests

  1984cited by this paper
• Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.

  1979cited by this paper
• Glucose-6-phosphate Dehydrogenase

  1974cited by this paper
• Hemagglutination by Rabies Virus

  1968cited by this paper
• CHAPTER 22 – EXPERIMENTAL TOXIC INJURY OF THE LIVER1

  1964cited by this paper
• Practical Clinical Chemistry

  1953cited by this paper
• Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria

  year unknowncited by this paper

• Photopolymerized pH-responsive GelMA microspheres with doxorubicin modification for embolization therapy

  2025cites this paper
• Investigation of plant virus-like particle formation in bacterial and yeast expression systems

  2024cites this paper
• Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy

  2023cites this paper
• Oral Delivery of Nanoparticles Carrying Ancestral Uricase Enzyme Protects against Hyperuricemia in Knockout Mice

  2023cites this paper
• Viral nanoparticles: Current advances in design and development.

  2023cites this paper
• The pharmacology of plant virus nanoparticles.

  2021cites this paper
• Plant virus-based materials for biomedical applications: Trends and prospects.

  2019cites this paper
• Menstrual Blood-Derived Stem Cells as Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer

  2019cites this paper
• Intracellular trafficking and endocytic uptake pathway of Pepper vein banding virus-like particles in epithelial cells.

  2019cites this paper
• Emerging Trends in the Development of Plant Virus-Based Nanoparticles and Their Biomedical Applications

  2019cites this paper
• Development of sesbania mosaic virus nanoparticles for imaging

  2018cites this paper
• Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo

  2017cites this paper
• Structural and Functional Characterization of Sesbania Mosaic Virus

  2017cites this paper